ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter
Sales rise 6.93% to Rs 790.15 crore
Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales790.15738.95 7 OPM %36.4835.80 -PBDT241.75209.59 15 PBT172.67129.11 34 NP120.1991.59 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2025 | 12:48 PM IST